Impact of age and comorbidity on presentation, aetiology and outcome in patients with community-acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
Influence of older age on biomarker concentrations in patients with community acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009
Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002
The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007
Clinical characteristics and symptoms in older and younger patients with community acquired pneumonia Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
The most frequent bacterial causes of pneumonia in children over 3 yrs of age - some characteristics Source: Eur Respir J 2002; 20: Suppl. 38, 191s Year: 2002
Clinical characteristics of the patients with community-acquired Legionella pneumonia in advanced age Source: Eur Respir J 2005; 26: Suppl. 49, 410s Year: 2005
Benralizumab efficacy in patients with uncontrolled eosinophilic asthma by age at diagnosis Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018
Differences in the clinical manifestation and diagnosis of TB in children and adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014
Recognising poor prognosis community-acquired pneumonia in young adults with simple clinical measurements Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006
Impact of age in the clinical expression of COPD Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008
Impact of age in the clinical expression of COPD in Greek patients Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009
Differences and characteristics of COVID-19 and atypical pneumonia Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021
Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia Source: Annual Congress 2004 - SARS and other lower respiratory tract infections Year: 2004
Influence of age, gender and respiratory function inpairment on acceptability for culture of sputum samples in microbiological study during acute exacerbation of chronic bronchitis Source: Eur Respir J 2003; 22: Suppl. 45, 217s Year: 2003
Evaluation of different predictive rules in young adults died from community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
Clinical, laboratory and ultrasound characteristics of different types of community-acquired pneumonia in children Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019
Clinical characteristics and outcomes of hospitalized COVID-19 pneumonia : impact of gender Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021
Prolonged hospitalization in community-acquired pneumonia. Influence of clinical factors and hospital characteristics Source: Eur Respir J 2003; 22: Suppl. 45, 544s Year: 2003